
### [Orphanet:444490](http://www.orpha.net/ORDO/Orphanet_444490)
**Label:** Familial chylomicronemia syndrome

**Subclasses:** [Orphanet:309020](http://www.orpha.net/ORDO/Orphanet_309020) (Familial apolipoprotein C-II deficiency), [Orphanet:309015](http://www.orpha.net/ORDO/Orphanet_309015) (Familial lipoprotein lipase deficiency), 

**Corr. equiv. classes:** [OMIM:207750](http://purl.obolibrary.org/obo/OMIM_207750), [Orphanet:309020](http://www.orpha.net/ORDO/Orphanet_309020), [OMIM:238600](http://purl.obolibrary.org/obo/OMIM_238600), [Orphanet:309015](http://www.orpha.net/ORDO/Orphanet_309015), 

**Class expressions from DL-Learner:**

- [HP:0031028](http://purl.obolibrary.org/obo/HP_0031028) (Lactescent serum) 62.50%
- [HP:0012238](http://purl.obolibrary.org/obo/HP_0012238) (Increased circulating chylomicron levels) and [HP:0031028](http://purl.obolibrary.org/obo/HP_0031028) (Lactescent serum) 62.50%
- [HP:0003124](http://purl.obolibrary.org/obo/HP_0003124) (Hypercholesterolemia) and [HP:0012238](http://purl.obolibrary.org/obo/HP_0012238) (Increased circulating chylomicron levels) 62.50%
- [HP:0002018](http://purl.obolibrary.org/obo/HP_0002018) (Nausea) and [HP:0012238](http://purl.obolibrary.org/obo/HP_0012238) (Increased circulating chylomicron levels) 62.50%
- [HP:0002013](http://purl.obolibrary.org/obo/HP_0002013) (Vomiting) and [HP:0012238](http://purl.obolibrary.org/obo/HP_0012238) (Increased circulating chylomicron levels) 62.50%
- [HP:0001744](http://purl.obolibrary.org/obo/HP_0001744) (Splenomegaly) and [HP:0012238](http://purl.obolibrary.org/obo/HP_0012238) (Increased circulating chylomicron levels) 62.50%
- [HP:0000007](http://purl.obolibrary.org/obo/HP_0000007) (Autosomal recessive inheritance) and [HP:0012238](http://purl.obolibrary.org/obo/HP_0012238) (Increased circulating chylomicron levels) 62.50%
- [HP:0012238](http://purl.obolibrary.org/obo/HP_0012238) (Increased circulating chylomicron levels) and [HP:0031028](http://purl.obolibrary.org/obo/HP_0031028) (Lactescent serum) and [HP:0100763](http://purl.obolibrary.org/obo/HP_0100763) (Abnormality of the lymphatic system) 62.50%
- [HP:0012238](http://purl.obolibrary.org/obo/HP_0012238) (Increased circulating chylomicron levels) and [HP:0025408](http://purl.obolibrary.org/obo/HP_0025408) (Abnormal spleen morphology) and [HP:0031028](http://purl.obolibrary.org/obo/HP_0031028) (Lactescent serum) 62.50%
- [HP:0012238](http://purl.obolibrary.org/obo/HP_0012238) (Increased circulating chylomicron levels) and [HP:0025142](http://purl.obolibrary.org/obo/HP_0025142) (Constitutional symptom) and [HP:0031028](http://purl.obolibrary.org/obo/HP_0031028) (Lactescent serum) 62.50%
- [HP:0012238](http://purl.obolibrary.org/obo/HP_0012238) (Increased circulating chylomicron levels) and [HP:0025032](http://purl.obolibrary.org/obo/HP_0025032) (Abnormality of digestive system physiology) and [HP:0031028](http://purl.obolibrary.org/obo/HP_0031028) (Lactescent serum) 62.50%
- [HP:0012238](http://purl.obolibrary.org/obo/HP_0012238) (Increased circulating chylomicron levels) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) and [HP:0031028](http://purl.obolibrary.org/obo/HP_0031028) (Lactescent serum) 62.50%
- [HP:0012238](http://purl.obolibrary.org/obo/HP_0012238) (Increased circulating chylomicron levels) and [HP:0012649](http://purl.obolibrary.org/obo/HP_0012649) (Increased inflammatory response) and [HP:0031028](http://purl.obolibrary.org/obo/HP_0031028) (Lactescent serum) 62.50%
- [HP:0012238](http://purl.obolibrary.org/obo/HP_0012238) (Increased circulating chylomicron levels) and [HP:0012647](http://purl.obolibrary.org/obo/HP_0012647) (Abnormal inflammatory response) and [HP:0031028](http://purl.obolibrary.org/obo/HP_0031028) (Lactescent serum) 62.50%
- [HP:0012238](http://purl.obolibrary.org/obo/HP_0012238) (Increased circulating chylomicron levels) and [HP:0012531](http://purl.obolibrary.org/obo/HP_0012531) (Pain) and [HP:0031028](http://purl.obolibrary.org/obo/HP_0031028) (Lactescent serum) 62.50%


